NEWS

News & Media

Podcasts, press coverage, and media mentions.

In the News

7 articles found

When Your Favorite Song Plays, Your Brain 'Physically Embodies' Music, Science Shows

New coverage of Neural Resonance Theory shows that brain cells don't just process music — they physically synchronize with it. This foundational science underpins Oscillo's entire therapeutic approach.

May 12, 2025|2 min readvia StudyFinds.orgView

News

Study Suggests We Don't Just Hear Music, but 'Become It'

McGill University coverage of Neural Resonance Theory introduces a powerful idea: the brain doesn't process music abstractly — it becomes it. The implications for neurotherapy, education, and technology are profound.

May 5, 2025|2 min readvia McGill University NewsroomView

News

Innovative Research Shows How the Brain Transforms Sound into Music

Oscillo announces the landmark Neural Resonance Theory publication and explains how it directly informs our ongoing clinical trial for Alzheimer's and mild cognitive impairment.

Apr 14, 2025|2 min readvia Oscillo BiosciencesView

News

Edward Large, Ph.D., to Be Honored at the Music Has Power® Symposium

Oscillo co-founder Dr. Edward Large was recognized at the prestigious Music Has Power® Symposium in New York for his pioneering research connecting music and brain health.

Nov 20, 2024|2 min readvia Institute for Music and Neurologic Function (IMNF)View

News

Can Listening to the Beatles Improve Your Memory?

Research from Northeastern's MIND Lab shows that personalized music playlists strengthen brain connectivity in older adults — and that self-selected songs like the Beatles work better than preselected music.

Oct 10, 2022|2 min readvia MedicalXpress / Northeastern UniversityView

News

Oscillo Biosciences Awarded Phase I SBIR Grant from the National Institute on Aging

A $449,695 NIH grant funds Oscillo's SynchronyGamma project — a music-based intervention for Alzheimer's disease and mild cognitive impairment.

Jun 29, 2022|1 min readvia Oscillo BiosciencesView

News

Oscillo Biosciences Awarded Competitive Grant from the National Science Foundation

A $224,846 NSF SBIR Phase I grant from America's Seed Fund supports early development of Oscillo's SynchronyGamma music-based intervention for Alzheimer's.

Aug 1, 2020|1 min readvia Oscillo BiosciencesView